Tumor-associated macrophages: Unwitting accomplices in breast cancer malignancy

381Citations
Citations of this article
661Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Deleterious inflammation is a primary feature of breast cancer. Accumulating evidence demonstrates that macrophages, the most abundant leukocyte population in mammary tumors, have a critical role at each stage of cancer progression. Such tumor-associated macrophages facilitate neoplastic transformation, tumor immune evasion and the subsequent metastatic cascade. Herein, we discuss the dynamic process whereby molecular and cellular features of the tumor microenvironment act to license tissue-repair mechanisms of macrophages, fostering angiogenesis, metastasis and the support of cancer stem cells. We illustrate how tumors induce, then exploit trophic macrophages to subvert innate and adaptive immune responses capable of destroying malignant cells. Finally, we discuss compelling evidence from murine models of cancer and early clinical trials in support of macrophage-targeted intervention strategies with the potential to dramatically reduce breast cancer morbidity and mortality.

Cite

CITATION STYLE

APA

Williams, C. B., Yeh, E. S., & Soloff, A. C. (2016, December 14). Tumor-associated macrophages: Unwitting accomplices in breast cancer malignancy. Npj Breast Cancer. Nature Publishing Group. https://doi.org/10.1038/npjbcancer.2015.25

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free